A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Clinical trial NCT06223880 · RECRUITING
Trial details
- NCT number
- NCT06223880
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2026-03-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.